Ghoulish Corporate Fascism and the Cost of Pharmaceuticals

October 12th, 2013

In the piece below, “Market competition among pharmaceutical companies,” means a market failure situation with cartel pricing.

Via: New York Times:

Thanks in part to the $250 million last year spent on lobbying for pharmaceutical and health products — more than even the defense industry — the government allows such practices. Lawmakers in Washington have forbidden Medicare, the largest government purchaser of health care, to negotiate drug prices. Unlike its counterparts in other countries, the United States Patient-Centered Outcomes Research Institute, which evaluates treatments for coverage by federal programs, is not allowed to consider cost comparisons or cost-effectiveness in its recommendations. And importation of prescription medicines from abroad is illegal, even personal purchases from mail-order pharmacies.

“Our regulatory and approval system seems constructed to achieve high-priced outcomes,” said Dr. Peter Bach, the director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center. “We don’t give any reason for drug makers to charge less.”

And taxpayers and patients bear the consequences.

Related: Vitamin D Asthma

Research Credit: ottilie

One Response to “Ghoulish Corporate Fascism and the Cost of Pharmaceuticals”

  1. tal says:

    June 27, 2013
    Maine Once Again Allows Mail-Order Canadian Drugs To Cut Costs
    http://www.npr.org/blogs/health/2013/06/27/196325173/maine-once-again-allows-mail-order-canadian-drugs-to-cut-costs

    September 22, 2013
    Big Pharma suing Maine to force drug monopoly on residents, block importation from Canada

    http://www.naturalnews.com/042172_Big_Pharma_drug_monopoly_lawsuit.html

Leave a Reply

You must be logged in to post a comment.